SCHEMBL4148202

SCHEMBL4148202

CN(C(=O)NC(=O)c1c(F)cccc1F)c1ccc(SC(F)(F)C(F)(F)F)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TLR7 Q9NYK1 4/20 0.37
MAPT P10636 2/20 0.36
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
POLB P06746 2/20 0.35
GAA P10253 3/20 0.35
IL2 P60568 1/20 0.35
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TLR8 Q9NR97 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
LMNA P02545 1/20 0.33
RORA P35398 1/20 0.33
RORB Q92753 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151007 0.91 TRPA1 (0.33) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4150976 0.91 MEN1 (0.39) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4157938 0.89 RORC (0.35) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4150885 0.88 MEN1 (0.39) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4163009 0.85 KMT2A (0.34) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4154057 0.85 TLR7 (0.40) RORCTLR7MAPTPOLBGAA
SCHEMBL4142542 0.84 ATM (0.42) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4158996 0.82 TRPA1 (0.34) RORCMEN1KMT2ATLR7MAPT
SCHEMBL4154004 0.82 TLR7 (0.42) RORCTLR7MAPTPOLBGAA
SCHEMBL4164252 0.82 RORC (0.40) RORCTLR7RORARORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RORC 4448/4885MEN1 1863/4885KMT2A 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.